dalteparin has been researched along with Cor Pulmonale in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, S | 1 |
| Wu, S | 1 |
| Chen, P | 1 |
1 trial available for dalteparin and Cor Pulmonale
| Article | Year |
|---|---|
[Chronic pulmonary heart diseases treated by fraxiparin].
Topics: Adult; Aged; Anticoagulants; Antithrombin III; Chronic Disease; Female; Fibrin Fibrinogen Degradatio | 1998 |